BioLattice

Revolutionizing Cornea Repair

Philadelphia, United States · Founded 2014 · $2.1M raised

Employees
1–10
Founded
2014
Business Model
B2B
Total Funding
$2.1M
Last Round
$1.8M Pre-SeedOct 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

BioLattice Ophthalmics is an award-winning tissue engineering company founded by Amelia Zellander, PhD (tissue engineer and pharmaceutical scientist) and Linda Alunkal, MBA. The company is developing CorneaClear, a synthetic corneal implant designed as a true alternative to donor corneas. With 2 million people suffering from corneal blindness annually and only 1 in 70 patients obtaining donor tissue, BioLattice's engineered cornea also offers corrective vision capabilities. The company has received funding from Life Sciences Greenhouse Investments (LSGI) and won multiple pitch competitions including HiveBio's Silicon Valley competition ($20K) and the Startup of the Year award. Based in Philadelphia and backed by federal grants before transitioning to VC funding.

Summary

BioLattice is a Biotech company based in Philadelphia, United States, founded in 2014. It has raised $2.1M in total across 2 rounds, most recently a $1.8M Pre-Seed round in Oct 2024.

Funding History

Pre-seedPre-SeedOct 2024
$1.8M

Sign up to see all 2 events

Funding: Grant through Pre-Seed. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BioLattice on Indexed.vc
<a href="https://indexed.vc/companies/biolattice"><img src="https://indexed.vc/api/badge/company/biolattice" alt="BioLattice on Indexed.vc" width="260" height="76" /></a>